News
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback